Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to boost alcohol treatment in mental health clinics

NCT ID NCT07053098

Recruiting now Knowledge-focused Sponsor: University of Maryland, Baltimore Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a program to help doctors in psychiatric clinics prescribe medications for alcohol use disorder to patients who also have serious mental illness. The program uses an external facilitator to work with clinic staff and overcome barriers to prescribing. The goal is to see if this approach increases the number of eligible patients who receive these medications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could show a practical way to increase use of alcohol use disorder medications in psychiatric care, improving treatment access for patients with both mental illness and alcohol problems.
What could go wrong
This is a small pilot study with only 40 participants, so results may not apply broadly. It focuses on changing doctor behavior, not directly testing a new drug or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alcohol abuse alcohol-related disorders bipolar disorder major depressive disorder post-traumatic stress disorder psychiatric disorder psychotic disorder schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOL-RELATED DISORDERS PSYCHIATRIC DISORDER

Contacts and locations

Locations

  • University of Maryland Baltimore

    RECRUITING

    Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.